Back

Decline over the years in the risk of cardiovascular events in patients with clinical manifest vascular disease is explained by change in cardiovascular risk factors and atherosclerotic burden.

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Lipoproteins and real life: what the randomized clinical trials do not show us Epidemiology, lipids ESC Premium Access ESC Congress 2016

About the speaker

Photo
Mr Gijs Berkelmans

University Medical Center Utrecht, Utrecht (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
State of the art in lipoproteins: lessons from real life registries
Professor B. Nordestgaard (Copenhagen, DK)
Slides Video
Presentation thumbnail
Utility of ApoB target over LDL-C and non-HDL-C targets: insights from the national health and nutrition examination survey (NHANES) 2011-2012
Doctor S. Martin (Baltimore, US)
Abstract Slides Video
Presentation thumbnail
Lipoprotein (Lp) (a) does not predict recurrent cardiovascular events in patients with stable coronary heart disease: 13-Year follow-up of the KAROLA study
Professor W. Koenig (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Future direction for research in lipids.
Professor E. Bruckert (Paris, FR)
Slides Video

Access the full session

Session thumbnail
Lipoproteins and real life: what the randomized clinical trials do not show us

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources